Towa Pharmaceutical Co., Ltd.
4553.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥49,576,000 | ¥35,015,000 | ¥45,471,000 | ¥29,252,000 |
| Short-Term Investments | ¥0 | ¥17,923,000 | ¥0 | ¥0 |
| Receivables | ¥56,934,000 | ¥58,758,000 | ¥71,631,000 | ¥68,318,000 |
| Inventory | ¥118,505,000 | ¥112,708,000 | ¥108,287,000 | ¥109,103,000 |
| Other Curr. Assets | ¥30,969,000 | ¥28,359,000 | ¥21,917,000 | ¥31,102,000 |
| Total Curr. Assets | ¥255,984,000 | ¥252,763,000 | ¥247,306,000 | ¥237,775,000 |
| Property Plant & Equip (Net) | ¥170,809,000 | ¥169,470,000 | ¥168,423,000 | ¥165,864,000 |
| Goodwill | ¥26,234,000 | ¥27,223,000 | ¥28,115,000 | ¥29,306,000 |
| Intangibles | ¥17,222,000 | ¥17,292,000 | ¥17,727,000 | ¥17,986,000 |
| Long-Term Investments | ¥963,000 | ¥862,000 | ¥1,377,000 | ¥846,000 |
| Tax Assets | ¥0 | ¥0 | ¥6,037,000 | ¥0 |
| Other NC Assets | ¥9,316,000 | ¥7,621,000 | ¥1,838,000 | ¥7,227,000 |
| Total NC Assets | ¥224,544,000 | ¥222,468,000 | ¥223,517,000 | ¥221,229,000 |
| Other Assets | ¥2,000 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥480,530,000 | ¥475,231,000 | ¥470,823,000 | ¥459,004,000 |
| Liabilities | – | – | – | – |
| Payables | ¥16,022,000 | ¥18,378,000 | ¥30,041,000 | ¥30,561,000 |
| Short-Term Debt | ¥29,598,000 | ¥27,969,000 | ¥24,105,000 | ¥15,569,000 |
| Tax Payable | ¥4,060,000 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥39,998,000 | ¥41,864,000 | ¥27,446,000 | ¥42,632,000 |
| Total Curr. Liab. | ¥91,282,000 | ¥89,651,000 | ¥87,939,000 | ¥78,689,000 |
| LT Debt | ¥192,069,000 | ¥196,529,000 | ¥195,077,000 | ¥197,083,000 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥4,325,000 | ¥4,375,000 | ¥4,378,000 | ¥4,533,000 |
| Total NC Liab. | ¥209,386,000 | ¥212,860,000 | ¥211,256,000 | ¥211,292,000 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥14,596,000 | ¥13,396,000 | ¥13,184,000 | ¥10,827,000 |
| Total Liabilities | ¥300,668,000 | ¥302,511,000 | ¥299,195,000 | ¥289,981,000 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥4,717,000 | ¥4,717,000 | ¥4,717,000 | ¥4,717,000 |
| Retained Earnings | ¥156,747,000 | ¥151,046,000 | ¥150,502,000 | ¥146,140,000 |
| AOCI | ¥16,140,000 | ¥14,702,000 | ¥14,149,000 | ¥15,909,000 |
| Other Equity | ¥1,000 | ¥0 | ¥2,000 | ¥2,000 |
| Total Equity | ¥179,862,000 | ¥172,720,000 | ¥171,625,000 | ¥169,023,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥480,530,000 | ¥475,231,000 | ¥470,823,000 | ¥459,004,000 |
| Net Debt | ¥172,091,000 | ¥189,483,000 | ¥173,711,000 | ¥183,400,000 |